Xiaochun Zheng

4PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 22, 2026
Economic evaluation of the second-line regimen of liposome irinotecan (II) combined with 5-FU/LV versus placebo combined with 5-FU/LV for locally advanced or metastatic pancreatic ductal adenocarcinoma in China.

|Oct 17, 2024
Real-world safety profile of zanubrutinib: a disproportionality analysis based on the FAERS database.

Jiangfeng Wang, Xiaochun Zheng, Jingyang Lin

|Feb 07, 2023
Cost-effectiveness analysis of anlotinib versus sunitinib as first-line treatment for metastatic renal cell carcinoma in China.

Jingyang Lin, Qingxia Fang, Xiaochun Zheng

|Sep 26, 2022
Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression.

Qingxia Fang, Jingyang Lin, Liang Gao

Pageof 1

Frequent Collaborators

2 joint publications

Jinlong Huang